Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.07 USD | -0.17% | +0.08% | -0.90% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.90% | 510M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-13.69% | 32.43B | |
+55.96% | 24.28B | |
-15.31% | 15.52B | |
-41.29% | 12.17B | |
-14.62% | 12.01B | |
-11.75% | 12B | |
+7.12% | 8.87B |
- Stock Market
- Equities
- KALV Stock
- News KalVista Pharmaceuticals, Inc.
- KalVista Pharmaceuticals' Phase 3 Trial of Sebetralstat to Treat Hereditary Angioedema Meets All Endpoints; Shares Rise